Gut Microbiota and DTI Microstructural Brain Alterations in Rodents Due to Morphine Self-Administration

Insights

Opioid use alters gut microbiota and brain structure, with gut changes preceding brain effects. Neuroinflammation links these changes, suggesting it as a therapeutic target for opioid use disorder.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pharmacology

Background:

  • The opioid epidemic necessitates interventions addressing chronic opioid use's maladaptive changes.
  • The gut-brain axis (GBA) is a bidirectional communication pathway affected in opioid use disorders.
  • Research is exploring complementary changes in the brain and gut during opioid exposure.

Purpose of the Study:

  • To longitudinally assess in-vivo, non-invasive changes in the brain and gut during morphine self-administration in rodents.
  • To investigate alterations in the acute (2 days) and chronic (2 weeks) phases of opioid self-administration.

Main Methods:

  • Rodents self-administered morphine via intravenous catheters.
  • Magnetic Resonance Imaging (MRI) and 16S rDNA fecal analysis were used to assess brain and gut changes.
  • Immunohistochemistry was performed on brain tissue to analyze neuroinflammatory markers.

Main Results:

  • Early changes in gut microbiota diversity and abundance were observed in the acute phase, persisting into the chronic phase.
  • MRI revealed alterations in diffusivity indices in the striatum, thalamus, and somatosensory cortex.
  • Increased neuroinflammatory markers were found in the thalamus of morphine-exposed rats.

Conclusions:

  • Morphine self-administration significantly shapes both the brain and gut microbiota.
  • Gut microbiota alterations precede observable anatomical changes in brain MRI features.
  • Neuroinflammation acts as a critical mediator in gut-brain communication, presenting a potential therapeutic target for opioid use impacts.